<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38754738</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-0260</ISSN><JournalIssue CitedMedium="Internet"><Volume>184</Volume><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Preventive medicine</Title><ISOAbbreviation>Prev Med</ISOAbbreviation></Journal><ArticleTitle>Long COVID among US adults from a population-based study: Association with vaccination, cigarette smoking, and the modifying effect of chronic obstructive pulmonary disease (COPD).</ArticleTitle><Pagination><StartPage>108004</StartPage><MedlinePgn>108004</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ypmed.2024.108004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0091-7435(24)00159-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Post-COVID Conditions (or Long COVID) have been widely reported, but population-based studies exploring the relationship between its risk factors are lacking. We examined the associations between Long COVID, chronic obstructive pulmonary disease [COPD], vaccination status, and cigarette smoking. We also tested for the modifying effect of COPD status.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from the 2022 US nationwide Behavioral Risk Factor Surveillance System (BRFSS) were analyzed. Our primary outcome was Long COVID (Yes/No) after a positive COVID-19 diagnosis. Predictor variables were COPD, coronary heart disease (CHD), diabetes, asthma, body mass index, cigarette smoking status, and number of COVID-19 vaccinations (0-4). Weighted multivariable logistic regression models were used and adjusted for sociodemographic factors. Regression models were used to explore the modifying effects of COPD status.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The weighted prevalence of Long COVID among survivors (N&#xa0;=&#xa0;121,379) was 21.8% (95%CI: 21.4, 22.3), with tiredness/fatigue (26.2% [95%:25.1, 27.2]) as the most common symptom. Respondents with COPD (aOR: 1.71 [95%CI: 1.45, 2.02]), current daily smokers (aOR: 1.23 [95%CI:1.01, 1.49]), and former smokers (aOR: 1.24 [95%CI:1.12, 1.38]) (vs. never established smokers) had higher odds of Long COVID. However, respondents who had received three (aOR: 0.75 [95%CI:0.65, 0.85]) and four (aOR: 0.71 [95%CI:0.58, 0.86]) vaccine doses (vs. no vaccine) had lower odds of Long COVID. COPD had a modifying effect on the relationship between cigarette smoking and Long COVID (p-value: 0.013).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings underscore a complex interaction between COPD, cigarette smoking, and Long COVID. Further, COVID-19 vaccination may be protective against Long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Erinoso</LastName><ForeName>Olufemi</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Health Behavior, Policy, and Administration Science, School of Public Health, University of Nevada, Reno, NV, USA. Electronic address: oerinoso@nevada.unr.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osibogun</LastName><ForeName>Olatokunbo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Robert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balakrishnan</LastName><ForeName>Siva</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Reno, NV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, University of Nevada, Reno, NV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K01 DA055127</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prev Med</MedlineTA><NlmUniqueID>0322116</NlmUniqueID><ISSNLinking>0091-7435</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="Y">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073865" MajorTopicYN="Y">Cigarette Smoking</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040343" MajorTopicYN="Y">Behavioral Risk Factor Surveillance System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cigarette smoking</Keyword><Keyword MajorTopicYN="N">Covid-19 disease</Keyword><Keyword MajorTopicYN="N">Long covid</Keyword><Keyword MajorTopicYN="N">Post-covid symptoms</Keyword><Keyword MajorTopicYN="N">Pulmonary disease</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>2</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>19</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38754738</ArticleId><ArticleId IdType="mid">NIHMS1998545</ArticleId><ArticleId IdType="pmc">PMC11148848</ArticleId><ArticleId IdType="doi">10.1016/j.ypmed.2024.108004</ArticleId><ArticleId IdType="pii">S0091-7435(24)00159-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BAKER AM, MAFFITT NJ, DEL VECCHIO A, MCKEATING KM, BAKER MR, BAKER SN &amp; SOTEROPOULOS DS 2023. Neural dysregulation in post-COVID fatigue. Brain Communications, 5, fcad122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10257363</ArticleId><ArticleId IdType="pubmed">37304792</ArticleId></ArticleIdList></Reference><Reference><Citation>BARNES PJ, BURNEY PG, SILVERMAN EK, CELLI BR, VESTBO J, WEDZICHA JA &amp; WOUTERS EF 2015. Chronic obstructive pulmonary disease. Nat Rev Dis Primers, 1, 15076.</Citation><ArticleIdList><ArticleId IdType="pubmed">27189863</ArticleId></ArticleIdList></Reference><Reference><Citation>BARTH&#xc9;L&#xc9;MY H, MOUGENOT E, DURACINSKY M, SALMON-CERON D, BONINI J, P&#xc9;RETZ F, CHASSANY O. &amp; CARRIERI P. 2022. Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey. Tobacco Induced Diseases, 20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9204712</ArticleId><ArticleId IdType="pubmed">35799625</ArticleId></ArticleIdList></Reference><Reference><Citation>BERLIN I, THOMAS D, LE FAOU A-L &amp; CORNUZ J. 2020. COVID-19 and Smoking. Nicotine &amp; Tobacco Research, 22, 1650&#x2013;1652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7184428</ArticleId><ArticleId IdType="pubmed">32242236</ArticleId></ArticleIdList></Reference><Reference><Citation>BONDY SJ, VICTOR JC &amp; DIEMERT LM 2009. Origin and use of the 100 cigarette criterion in tobacco surveys. Tobacco Control, 18, 317.</Citation><ArticleIdList><ArticleId IdType="pubmed">19491091</ArticleId></ArticleIdList></Reference><Reference><Citation>BULL-OTTERSON L, BACA S, SAYDAH S, BOEHMER TK, ADJEI S, GRAY S. &amp; HARRIS AM 2022. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and&#x2265; 65 years&#x2014;United States, March 2020&#x2013;November 2021. Morbidity and Mortality Weekly Report, 71, 713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9368731</ArticleId><ArticleId IdType="pubmed">35925799</ArticleId></ArticleIdList></Reference><Reference><Citation>BYAMBASUREN O, STEHLIK P, CLARK J, ALCORN K. &amp; GLASZIOU P. 2023. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med, 2, e000385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Stay Up to Date with COVID-19 Vaccines [Online]. Centers for Disease Control and Prevention. Available: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html [Accessed January 1st 2024 2024].</Citation></Reference><Reference><Citation>CDC 2023. Long COVID or Post-COVID Conditions. July 20th 2023 ed: Centers for Disease Control and Prevention.</Citation></Reference><Reference><Citation>CDC, U. 2022. 2022 BRFSS Survey Data and Documentation. US Centers for Disease Control and Prevention.</Citation></Reference><Reference><Citation>CHARFEDDINE S, IBN HADJ AMOR H, JDIDI J, TORJMEN S, KRAIEM S, HAMMAMI R, BAHLOUL A, KALLEL N, MOUSSA N. &amp; TOUIL I. 2021. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction. Insights From TUN-EndCOV Study. Front. Cardiovasc. Med, 8, 745758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>CHEN C, HAUPERT SR, ZIMMERMANN L, SHI X, FRITSCHE LG &amp; MUKHERJEE B. 2022. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis, 226, 1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>CHEVINSKY JR, TAO G, LAVERY AM, KUKIELKA EA, CLICK ES, MALEC D, KOMPANIYETS L, BRUCE BB, YUSUF H. &amp; GOODMAN AB 2021. Late conditions diagnosed 1&#x2013;4 months following an initial coronavirus disease 2019 (COVID-19) encounter: a matched-cohort study using inpatient and outpatient administrative data&#x2014;United States, 1 March&#x2013;30 June 2020. Clinical Infectious Diseases, 73, S5&#x2013;S16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8135331</ArticleId><ArticleId IdType="pubmed">33909072</ArticleId></ArticleIdList></Reference><Reference><Citation>DAVIS HE, ASSAF GS, MCCORKELL L, WEI H, LOW RJ, RE&#x2019;EM Y, REDFIELD S, AUSTIN JP &amp; AKRAMI A. 2021. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine, 38, 101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>DAVIS HE, MCCORKELL L, VOGEL JM &amp; TOPOL EJ 2023. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol, 21, 133&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>DEL SOLE F, FARCOMENI A, LOFFREDO L, CARNEVALE R, MENICHELLI D, VICARIO T, PIGNATELLI P. &amp; PASTORI D. 2020. Features of severe COVID-19: a systematic review and meta-analysis. European journal of clinical investigation, 50, e13378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435565</ArticleId><ArticleId IdType="pubmed">32860457</ArticleId></ArticleIdList></Reference><Reference><Citation>FOREY BA, THORNTON AJ &amp; LEE PN 2011. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC pulmonary medicine, 11, 1&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128042</ArticleId><ArticleId IdType="pubmed">21672193</ArticleId></ArticleIdList></Reference><Reference><Citation>FRONTERA JA, LEWIS A, MELMED K, LIN J, KONDZIELLA D, HELBOK R, YAGHI S, MEROPOL S, WISNIEWSKI T. &amp; BALCER L. 2021. Prevalence and predictors of prolonged cognitive and psychological symptoms following COVID-19 in the United States. Frontiers in aging neuroscience, 13, 690383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326803</ArticleId><ArticleId IdType="pubmed">34349633</ArticleId></ArticleIdList></Reference><Reference><Citation>FUNG KW, BAYE F, BAIK SH, ZHENG Z. &amp; MCDONALD CJ 2023. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLOS Medicine, 20, e1004194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId></ArticleIdList></Reference><Reference><Citation>GAO YD, DING M, DONG X, ZHANG JJ, KURSAT AZKUR A, AZKUR D, GAN H, SUN YL, FU W. &amp; LI W. 2021. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy, 76, 428&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>GLYNNE P, TAHMASEBI N, GANT V. &amp; GUPTA R. 2022. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. Journal of Investigative Medicine, 70, 61&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>GROFF D, SUN A, SSENTONGO AE, BA DM, PARSONS N, POUDEL GR, LEKOUBOU A, OH JS, ERICSON JE, SSENTONGO P. &amp; CHINCHILLI VM 2021. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Network Open, 4, e2128568&#x2013;e2128568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>HAFFKE M, FREITAG H, RUDOLF G, SEIFERT M, DOEHNER W, SCHERBAKOV N, HANITSCH L, WITTKE K, BAUER S. &amp; KONIETSCHKE F. 2022. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine, 20, 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>HEIJINK IH, HACKETT TL &amp; POUWELS SD 2021. Effects of cigarette smoking on SARS-CoV-2 receptor ACE2 expression in the respiratory epithelium(&#x2020;). J Pathol, 253, 351&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7986690</ArticleId><ArticleId IdType="pubmed">33368245</ArticleId></ArticleIdList></Reference><Reference><Citation>HIRSCHTICK JL, XIE Y, SLOCUM E, HIRSCHTICK RE, POWER LE, ELLIOTT MR, ORELLANA RC &amp; FLEISCHER NL 2023. A statewide population-based approach to examining Long COVID symptom prevalence and predictors in Michigan. Preventive Medicine, 177, 107752.</Citation><ArticleIdList><ArticleId IdType="pubmed">37944672</ArticleId></ArticleIdList></Reference><Reference><Citation>HOFFMANN M, KLEINE-WEBER H, SCHROEDER S, KR&#xdc;GER N, HERRLER T, ERICHSEN S, SCHIERGENS TS, HERRLER G, WU NH, NITSCHE A, M&#xdc;LLER MA, DROSTEN C. &amp; P&#xd6;HLMANN S. 2020. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell, 181, 271&#x2013;280.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>HORWITZ LI, THAWEETHAI T, BROSNAHAN SB, CICEK MS, FITZGERALD ML, GOLDMAN JD, HESS R, HODDER S, JACOBY VL &amp; JORDAN MR 2023. Researching COVID to Enhance Recovery (RECOVER) adult study protocol: Rationale, objectives, and design. Plos one, 18, e0286297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10289397</ArticleId><ArticleId IdType="pubmed">37352211</ArticleId></ArticleIdList></Reference><Reference><Citation>HUANG Y, PINTO MD, BORELLI JL, ASGARI MEHRABADI M, ABRAHIM HL, DUTT N, LAMBERT N, NURMI EL, CHAKRABORTY R. &amp; RAHMANI AM 2022. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler looking for clarity in the haze of the pandemic. Clinical nursing research, 31, 1390&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>IMAI Y, KUBA K, RAO S, HUAN Y, GUO F, GUAN B, YANG P, SARAO R, WADA T. &amp; LEONG-POI H. 2005. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature, 436, 112&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094998</ArticleId><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference><Reference><Citation>JACOBS M, VAN EECKHOUTTE HP, WIJNANT SRA, JANSSENS W, JOOS GF, BRUSSELLE GG &amp; BRACKE KR 2020. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects. Eur Respir J, 56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366177</ArticleId><ArticleId IdType="pubmed">32675207</ArticleId></ArticleIdList></Reference><Reference><Citation>KLEIN J, WOOD J, JAYCOX JR, DHODAPKAR RM, LU P, GEHLHAUSEN JR, TABACHNIKOVA A, GREENE K, TABACOF L. &amp; MALIK AA 2023. Distinguishing features of Long COVID identified through immune profiling. Nature, 623, 139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>KLEMPERER EM, HUGHES JR, CALLAS PW, WEST JC &amp; VILLANTI AC 2021. Tobacco and Nicotine Use Among US Adult &#x201c;Never Smokers&#x201d; in Wave 4 (2016&#x2013;2018) of the Population Assessment of Tobacco and Health Study. Nicotine Tob Res, 23, 1199&#x2013;1207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8186421</ArticleId><ArticleId IdType="pubmed">33433608</ArticleId></ArticleIdList></Reference><Reference><Citation>LEUNG JM, YANG CX, TAM A, SHAIPANICH T, HACKETT TL, SINGHERA GK, DORSCHEID DR &amp; SIN DD 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J, 55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144263</ArticleId><ArticleId IdType="pubmed">32269089</ArticleId></ArticleIdList></Reference><Reference><Citation>LIPPI G. &amp; HENRY BM 2020. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). European journal of internal medicine, 75, 107&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118593</ArticleId><ArticleId IdType="pubmed">32192856</ArticleId></ArticleIdList></Reference><Reference><Citation>LIU A, ZHANG X, LI R, ZHENG M, YANG S, DAI L, WU A, HU C, HUANG Y, XIE M. &amp; CHEN Q. 2021. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia. J Pathol, 253, 17&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537258</ArticleId><ArticleId IdType="pubmed">32991738</ArticleId></ArticleIdList></Reference><Reference><Citation>MALIK P, PATEL K, PINTO C, JAISWAL R, TIRUPATHI R, PILLAI S. &amp; PATEL U. 2022. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. Journal of medical virology, 94, 253&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>MARRA AR, KOBAYASHI T, SUZUKI H, ALSUHAIBANI M, HASEGAWA S, THOLANY J, PERENCEVICH E, MAEZATO AM, RICARDO VCV, SALINAS JL, EDMOND MB &amp; RIZZO LV 2022. The effectiveness of coronavirus disease 2019 (COVID-19) vaccine in the prevention of post-COVID-19 conditions: A systematic literature review and meta-analysis. Antimicrob Steward Healthc Epidemiol, 2, e192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9726631</ArticleId><ArticleId IdType="pubmed">36505947</ArticleId></ArticleIdList></Reference><Reference><Citation>NOTARTE KI, CATAHAY JA, VELASCO JV, PASTRANA A, VER AT, PANGILINAN FC, PELIGRO PJ, CASIMIRO M, GUERRERO JJ &amp; GELLACO MML 2022. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine, 53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;MAHONEY LL, ROUTEN A, GILLIES C, EKEZIE W, WELFORD A, ZHANG A, KARAMCHANDANI U, SIMMS-WILLIAMS N, CASSAMBAI S. &amp; ARDAVANI A. 2023. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine, 55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>OAKES JM, FUCHS RM, GARDNER JD, LAZARTIGUES E. &amp; YUE X. 2018. Nicotine and the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol, 315, R895&#x2013;r906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6295500</ArticleId><ArticleId IdType="pubmed">30088946</ArticleId></ArticleIdList></Reference><Reference><Citation>ORGANIZATION, W. H. 2021. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. World Health Organization.</Citation></Reference><Reference><Citation>PATANAVANICH R. &amp; GLANTZ SA 2020. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine &amp; Tobacco Research, 22, 1653&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239135</ArticleId><ArticleId IdType="pubmed">32399563</ArticleId></ArticleIdList></Reference><Reference><Citation>PATEL MA, KNAUER MJ, NICHOLSON M, DALEY M, VAN NYNATTEN LR, MARTIN C, PATTERSON EK, CEPINSKAS G, SENEY SL, DOBRETZBERGER V, MIHOLITS M, WEBB B. &amp; FRASER DD 2022. Elevated vascular transformation blood biomarkers in Long-COVID indicate angiogenesis as a key pathophysiological mechanism. Molecular Medicine, 28, 122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9549814</ArticleId><ArticleId IdType="pubmed">36217108</ArticleId></ArticleIdList></Reference><Reference><Citation>PERLIS RH, SANTILLANA M, OGNYANOVA K, SAFARPOUR A, LUNZ TRUJILLO K, SIMONSON MD, GREEN J, QUINTANA A, DRUCKMAN J, BAUM MA &amp; LAZER D. 2022. Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Network Open, 5, e2238804&#x2013;e2238804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>PHETSOUPHANH C, DARLEY DR, WILSON DB, HOWE A, MUNIER CML, PATEL SK, JUNO JA, BURRELL LM, KENT SJ &amp; DORE GJ 2022. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature immunology, 23, 210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>PRETORIUS E, VENTER C, LAUBSCHER GJ, KOTZE MJ, OLADEJO SO, WATSON LR, RAJARATNAM K, WATSON BW &amp; KELL DB 2022. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC). Cardiovascular diabetology, 21, 148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>PROAL AD &amp; VANELZAKKER MB 2021. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Frontiers in microbiology, 12, 1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>QASMIEH SA, ROBERTSON MM, TEASDALE CA, KULKARNI SG, JONES HE, MCNAIRY M, BORRELL LN &amp; NASH D. 2023. The prevalence of SARS-CoV-2 infection and long COVID in U.S. adults during the BA.4/BA.5 surge, June&#x2013;July 2022. Preventive Medicine, 169, 107461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9940463</ArticleId><ArticleId IdType="pubmed">36813250</ArticleId></ArticleIdList></Reference><Reference><Citation>REDDY RK, CHARLES WN, SKLAVOUNOS A, DUTT A, SEED PT &amp; KHAJURIA A. 2021. The effect of smoking on COVID-19 severity: A systematic review and meta-analysis. Journal of medical virology, 93, 1045&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436545</ArticleId><ArticleId IdType="pubmed">32749705</ArticleId></ArticleIdList></Reference><Reference><Citation>SINGH D, MATHIOUDAKIS AG &amp; HIGHAM A. 2022. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Curr Opin Pulm Med, 28, 76&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8815646</ArticleId><ArticleId IdType="pubmed">34690257</ArticleId></ArticleIdList></Reference><Reference><Citation>SORIANO JB, MURTHY S, MARSHALL JC, RELAN P. &amp; DIAZ JV 2022. A clinical case definition of post-COVID-19 condition by a Delphi consensus. The Lancet Infectious Diseases, 22, e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>SUBRAMANIAN A, NIRANTHARAKUMAR K, HUGHES S, MYLES P, WILLIAMS T, GOKHALE KM, TAVERNER T, CHANDAN JS, BROWN K, SIMMS-WILLIAMS N, SHAH AD, SINGH M, KIDY F, OKOTH K, HOTHAM R, BASHIR N, COCKBURN N, LEE SI, TURNER GM, GKOUTOS GV, AIYEGBUSI OL, MCMULLAN C, DENNISTON AK, SAPEY E, LORD JM, WRAITH DC, LEGGETT E, ILES C, MARSHALL T, PRICE MJ, MARWAHA S, DAVIES EH, JACKSON LJ, MATTHEWS KL, CAMARADOU J, CALVERT M. &amp; HAROON S. 2022. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med, 28, 1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>SWANK Z, SENUSSI Y, MANICKAS-HILL Z, YU XG, LI JZ, ALTER G. &amp; WALT DR 2023. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clinical Infectious Diseases, 76, e487&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>TABACOF L, TOSTO-MANCUSO J, WOOD J, CORTES M, KONTOROVICH A, MCCARTHY D, RIZK D, ROZANSKI G, BREYMAN E. &amp; NASR L. 2022. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. American journal of physical medicine &amp; rehabilitation, 101, 48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8667685</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>TENFORDE MW, DEVINE OJ, REESE HE, SILK BJ, IULIANO AD, THRELKEL R, VU QM, PLUMB ID, CADWELL BL, ROSE C, STEELE MK, BRIGGS-HAGEN M, AYOUBKHANI D, PAWELEK P, NAFILYAN V, SAYDAH SH &amp; BERTOLLI J. 2023. Point Prevalence Estimates of Activity-Limiting Long-term Symptoms Among United States Adults &#x2265;1 Month After Reported Severe Acute Respiratory Syndrome Coronavirus 2 Infection, 1 November 2021. J Infect Dis, 227, 855&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278232</ArticleId><ArticleId IdType="pubmed">35776165</ArticleId></ArticleIdList></Reference><Reference><Citation>TOMCHANEY M, CONTOLI M, MAYO J, BARALDO S, LI S, CABEL C, BULL D, LICK S, MALO J. &amp; KNOPER S. 2021. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease. BMC Pulmonary Medicine, 21, 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381712</ArticleId><ArticleId IdType="pubmed">34425811</ArticleId></ArticleIdList></Reference><Reference><Citation>TSAMPASIAN V, ELGHAZALY H, CHATTOPADHYAY R, DEBSKI M, NAING TKP, GARG P, CLARK A, NTATSAKI E. &amp; VASSILIOU VS 2023. Risk Factors Associated With Post&#x2212;COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Internal Medicine, 183, 566&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>VARDAVAS CI &amp; NIKITARA K. 2020. COVID-19 and smoking: A systematic review of the evidence. Tobacco induced diseases, 18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7083240</ArticleId><ArticleId IdType="pubmed">32206052</ArticleId></ArticleIdList></Reference><Reference><Citation>VECCHIO J, REGAN J, JIANG Y, LI R, ROMAIN H, YOUSUF F, ADEL T, HALL K, DACOSTA JM, YU X, LI JZ &amp; FOFANA IB 2023. Viral and immunologic evaluation of smokers with severe COVID-19. Scientific Reports, 13, 17898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10587108</ArticleId><ArticleId IdType="pubmed">37857680</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO 2023. Coronavirus disease (COVID-19). August 2023 ed: World Health Organization.</Citation></Reference><Reference><Citation>WISNIVESKY JP, GOVINDARAJULU U, BAGIELLA E, GOSWAMI R, KALE M, CAMPBELL KN, MELIAMBRO K, CHEN Z, ABERG JA &amp; LIN JJ 2022. Association of vaccination with the persistence of post-COVID symptoms. Journal of general internal medicine, 37, 1748&#x2013;1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906626</ArticleId><ArticleId IdType="pubmed">35266128</ArticleId></ArticleIdList></Reference><Reference><Citation>WORLDOMETER 2023. COVID-19 CORONAVIRUS PANDEMIC. Worldometer. Online.</Citation></Reference><Reference><Citation>YOSHIDA T. &amp; TUDER RM 2007. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiological reviews, 87, 1047&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">17615396</ArticleId></ArticleIdList></Reference><Reference><Citation>ZUBCHENKO S, KRIL I, NADIZHKO O, MATSYURA O. &amp; CHOPYAK V. 2022. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatology International, 42, 1523&#x2013;1530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>